OpenBilldrug price receipt

NADAC week of 2026-10-14

OXCARBAZEPINE 600 MG TABLET

For 30 tablets

Pharmacies pay

$9.51 filed

30 × $0.31696 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$15.94 estimated

$9.51 + $1.43 (15%) + $5.00 fee per fill = $15.94

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

OXCARBAZEPINE 600 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as oxcarbazepine.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Camber Pharmaceuticals, Inc. and AvPAK.

FDA’s Established Pharmacologic Class for it is Anti-epileptic Agent.

The NADAC file of 2026-10-14 prices it under 19 NDCs (National Drug Codes); the FDA directory lists 17 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $9.51 for 30 tablets (30 × $0.31696 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 9 labelers

LabelerNDCsPharmacies pay per unit
Advagen Pharma Limited4$0.31696 per EA filed
Breckenridge Pharmaceutical, Inc.4$0.31696 per EA filed
ANI Pharmaceuticals, Inc.2$0.31696 per EA filed
NorthStar RxLLC2$0.31696 per EA filed
American Health Packaging1$0.31696 per EA filed
AvPAK1$0.31696 per EA filed
Camber Pharmaceuticals, Inc.1$0.31696 per EA filed
Glenmark Pharmaceuticals Inc., USA1$0.31696 per EA filed
Major Pharmaceuticals1$0.31696 per EA filed
Not listed as a package in the FDA directory2$0.31696 per EA filed
All 19 NDCs, with labeler and price
  • 00904-7264-61 · Major Pharmaceuticals · $0.31696 per EA · eff. 2026-09-23 filed
  • 31722-0025-01 · Camber Pharmaceuticals, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 50268-0681-11 · not listed as a package in the FDA directory · $0.31696 per EA · eff. 2026-09-23 filed
  • 50268-0681-15 · AvPAK · $0.31696 per EA · eff. 2026-09-23 filed
  • 51991-0055-01 · Breckenridge Pharmaceutical, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 51991-0055-05 · Breckenridge Pharmaceutical, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 51991-0294-01 · Breckenridge Pharmaceutical, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 51991-0294-05 · Breckenridge Pharmaceutical, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 60687-0733-01 · American Health Packaging · $0.31696 per EA · eff. 2026-09-23 filed
  • 60687-0733-11 · not listed as a package in the FDA directory · $0.31696 per EA · eff. 2026-09-23 filed
  • 62559-0222-01 · ANI Pharmaceuticals, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 62559-0222-05 · ANI Pharmaceuticals, Inc. · $0.31696 per EA · eff. 2026-09-23 filed
  • 68462-0139-01 · Glenmark Pharmaceuticals Inc., USA · $0.31696 per EA · eff. 2026-09-23 filed
  • 72603-0272-01 · NorthStar RxLLC · $0.31696 per EA · eff. 2026-09-23 filed
  • 72603-0272-02 · NorthStar RxLLC · $0.31696 per EA · eff. 2026-09-23 filed
  • 72888-0089-01 · Advagen Pharma Limited · $0.31696 per EA · eff. 2026-09-23 filed
  • 72888-0089-05 · Advagen Pharma Limited · $0.31696 per EA · eff. 2026-09-23 filed
  • 72888-0461-01 · Advagen Pharma Ltd. · $0.31696 per EA · eff. 2026-09-23 filed
  • 72888-0461-02 · Advagen Pharma Ltd. · $0.31696 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

13 other products in the NADAC file share the FDA nonproprietary name oxcarbazepine with OXCARBAZEPINE 600 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
OXCARBAZEPINE 150 MG TABLET
generic · tablet, film coated / tablet
$0.10623 per EA filed
eff. 2026-09-23
We don’t know yet
OXCARBAZEPINE 300 MG TABLET
generic · tablet, film coated / tablet
$0.16669 per EA filed
eff. 2026-09-23
We don’t know yet
OXCARBAZEPINE 300 MG/5 ML SUSP
generic · suspension
$0.11023 per ML filed
eff. 2026-09-23
We don’t know yet
OXCARBAZEPINE 600 MG TABLET this page
generic · tablet, film coated / tablet
$0.31696 per EA filed
eff. 2026-09-23
We don’t know yet
OXCARBAZEPINE ER 150 MG TABLET
generic · tablet, extended release
$3.49768 per EA filed
eff. 2026-09-23
$12.28128 per EA filed
Part D 2024 average
OXCARBAZEPINE ER 300 MG TABLET
generic · tablet, extended release
$4.73052 per EA filed
eff. 2026-09-23
$12.28128 per EA filed
Part D 2024 average
OXCARBAZEPINE ER 600 MG TABLET
generic · tablet, extended release
$9.5783 per EA filed
eff. 2026-09-23
$12.28128 per EA filed
Part D 2024 average
OXTELLAR XR 150 MG TABLET
brand · tablet
$9.02471 per EA filed
eff. 2026-09-23
$17.96079 per EA filed
Part D 2024 average
OXTELLAR XR 300 MG TABLET
brand · tablet
$12.75205 per EA filed
eff. 2026-09-23
$17.96079 per EA filed
Part D 2024 average
OXTELLAR XR 600 MG TABLET
brand · tablet
$23.29894 per EA filed
eff. 2026-09-23
$17.96079 per EA filed
Part D 2024 average
TRILEPTAL 150 MG TABLET
brand · tablet, film coated
$5.72156 per EA filed
eff. 2026-01-07
We don’t know yet
TRILEPTAL 300 MG TABLET
brand · tablet, film coated
$10.45435 per EA filed
eff. 2026-09-23
We don’t know yet
TRILEPTAL 300 MG/5 ML SUSP
brand · suspension
$1.93077 per ML filed
eff. 2026-09-23
We don’t know yet
TRILEPTAL 600 MG TABLET
brand · tablet, film coated
$19.33273 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-07, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 19 NDCs’ NADAC prices is $0.31696 per EA filed.

Of the 85 other products in FDA’s Anti-epileptic Agent class priced per EA, 54 have a higher middle NADAC price and 31 a lower one. The one in the middle is PHENYTEK 200 MG CAPSULE, at $1.4026 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.